4//SEC Filing
Simeonidis Simos 4
Accession 0001209191-22-035864
CIK 0001505512other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 4:16 PM ET
Size
5.6 KB
Accession
0001209191-22-035864
Insider Transaction Report
Form 4
Simeonidis Simos
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-09+90,000→ 90,000 totalExercise: $0.27Exp: 2032-06-09→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]Pursuant to the Company's Non Employee Director's Compensation policy, the options are automatically granted on the date of the Company's Annual Meeting of Stockholders and will vest ratably over the following twelve months such that the option will be fully vested one year after the date of grant or on the date of the Company's next annual stockholder meeting, whichever occurs first, subject to the Reporting Person's continuous service.
Documents
Issuer
Regulus Therapeutics Inc.
CIK 0001505512
Entity typeother
Related Parties
1- filerCIK 0001778545
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 4:16 PM ET
- Size
- 5.6 KB